ZIP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZIP is not a good buy right now for an impatient investor. The stock is technically in a persistent downtrend (bearish moving-average stack) and the pattern-based forward odds skew negative over the next month (-4.05%). While it’s short-term oversold and sitting near support (which can produce a quick bounce), there is no proprietary buy signal, no fresh news catalyst, and fundamentals still show declining revenue. Best call: hold off rather than chase an oversold bounce.
Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating price weakness across short-, medium-, and long-term timeframes. Momentum: MACD histogram is negative (-0.00514) but contracting, which often signals downside momentum is fading (possible stabilization), not a confirmed reversal. RSI: RSI_6 at ~27 indicates oversold conditions (despite the label shown), which can support a short-lived rebound. Levels: Price 2.46 is just above S1 (2.406). A breakdown below ~2.41 increases risk toward S2 (2.237). Upside resistance is the pivot 2.679, then R1 2.952. Short-horizon bias: Similar-pattern projection suggests a modest next-day lift (+2.01%) but flat-to-down beyond that (-0.36% next week, -4.05% next month), aligning with a bear-trend/oversold-bounce setup rather than a durable uptrend.
could spark a quick mean-reversion bounce.
Primary trend remains down (bearish MA stack), so rallies are more likely to be sold until trend changes.
No news in the last week—no near-term event-driven catalyst to re-rate the stock.
Pattern-based outlook indicates downside bias over the next month (-4.05%).
Revenue is still shrinking (2025/Q3 revenue -1.80% YoY), which limits fundamental support for sustained upside.
No supportive signal from Intellectia modules today (reduces confidence for an immediate entry).
Latest quarter: 2025/Q3. Revenue declined to $114.982M (-1.80% YoY), showing continued top-line pressure. Profitability trend improved: Net income was -$9.822M (loss narrowed significantly, +282.18% YoY improvement) and EPS was -$0.11 (+266.67% YoY improvement), indicating costs and/or monetization are improving versus last year. Margins: Gross margin dipped slightly to 89.12% (-0.34% YoY), still very high but not expanding. Overall: Improving loss profile, but without revenue growth the upside case is more “stabilization/turnaround” than “growth acceleration” right now.
Recent analyst actions (2025-11-06): UBS raised PT to $4.50 (from $4) and Goldman Sachs raised PT to $5.50 (from $5); both maintained Neutral ratings. Interpretation: Wall Street is modestly more constructive on valuation/longer-term recovery (higher targets) but not confident enough to recommend buying (ratings stayed Neutral). Street pros: Potential upside from depressed price levels and improving profitability. Street cons: Unclear revenue re-acceleration and weak price trend keep conviction muted. Influential/insider/political flows: Hedge funds and insiders show neutral activity; no recent Congress trading data available.
Intellectia Proprietary Trading Signals
